Status:
NOT_YET_RECRUITING
A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis
Lead Sponsor:
RenJi Hospital
Conditions:
the Dynamic Evolution of Endometrial Carcinogenesis
Multiomics Analysis
Eligibility:
FEMALE
18+ years
Brief Summary
The goal of this observational study is to draw the characteristic maps of imaging omics, genomics, transcriptome, proteomics, pathological omics, metabolomics, etc. of the dynamic evolution of endome...
Eligibility Criteria
Inclusion
- Pathological diagnosis: normal endometrium, atypical hyperplasia endometrium, or endometrial cancer;
- Obtain pathological results after undergoing hysteroscopic surgery or hysterectomy;
- The patient voluntarily participated in this research project with good compliance and was able to complete the enrollment according to the experimental requirements;
- Sign the informed consent form and consent to the collection and use of their data, and consent to genomics, transcriptome and other tests.
Exclusion
- Patients with malignant tumors in other parts of the body;
- Suffering from uncontrollable neurological diseases, psychiatric diseases, or psychiatric disorders;
- Poor compliance and inability to cooperate and describe treatment responders.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06007300
Start Date
August 1 2023
End Date
June 1 2026
Last Update
August 23 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.